Global Genomic Medicine Consortium (G2MC)
This presentation disucesses how the Clalit 100K Israeli Genomes RCT is testing the genomic medicine paradigm in practice. Specifically, Dr. Rennert discusses the current status of the trial, the foreseen outcomes, and the study's phases and next steps.
Presentations in Session II: Genomics of Common Disorders
